Metraipolis › archive › dc_2a1e92fb75db

Managed Entry Agreements for Pharmaceutical Products in Three Maghreb Countries: Payer and Supplier Perspectives — Europe PMC PMID:40860955

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40860955
DOI
10.3390/jmahp13030040
License (as archived)
solo-consultazione
Archived
2026-11-10T17:44:44.356Z
SHA-256 of the archived text
c532915c19557e77adcf6c69320392915c384676e9bd80f1b4faa30320905749
Stable URL of this page
https://metraipolis.com/documento/dc_2a1e92fb75db

How to cite

Managed Entry Agreements for Pharmaceutical Products in Three Maghreb Countries: Payer and Supplier Perspectives — Europe PMC PMID:40860955 — Europe PMC (en), https://europepmc.org/article/MED/40860955 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2a1e92fb75db (Metraipolis archive dc_2a1e92fb75db, sha256 c532915c19557e77adcf6c69320392915c384676e9bd80f1b4faa30320905749)
BibTeX
@misc{dc2a1e92fb75db,
  title = {Managed Entry Agreements for Pharmaceutical Products in Three Maghreb Countries: Payer and Supplier Perspectives — Europe PMC PMID:40860955},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40860955},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2a1e92fb75db; sha256 c532915c19557e77adcf6c69320392915c384676e9bd80f1b4faa30320905749},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40860955. Agents can read the archived copy with the MCP tool read_document.